Robertson AH, Wolf AS, Fossum E, Solum G, Bhandari S, Vikse EL, Kjønstad IF, Magnus P, Nygaard UC, Lund-Johansen F, Trogstad L, Mjaaland S(2026) Long-lasting cross-reactive and polyfunctional SARS-CoV-2 T cell responses in seniors are maintained after repeated vaccination and infections Vaccine, 80, 128511(in press) DOI 10.1016/j.vaccine.2026.128511, PubMed 41895154
Rasmussen TH, Schikora-Rustad S, Lorentzen ÅR, Tran TT, Øverås MH, Myhr KM, Wergeland S, Aarseth J, Bø L, Berge T, Høgestøl EA, Harbo HF, Tveter AT, Jørgensen KK, Cunen C, Torkildsen Ø, Holmøy T, Celius EG, Vaage JT, Nygaard GO, Lund-Johansen F, König M(2026) Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study BMJ Neurol Open, 8(1), e001556 DOI 10.1136/bmjno-2026-001556, PubMed 41835014
Douvlataniotis K, Titov A, Zeun J, Bilici M, Palashati H, Loh W, Rustad EH, Yang W, Tran TT, Lund-Johansen F, Bollineni RC, Kepple JD, Huth LP, Munthe LA, Boxaspen T, Schjesvold F, Waage A, Wagner DL, Bull KR, Hester J, Issa F, Giannakopoulou E, Olweus J(2026) TCR T cells targeting IgA- and IgG-expressing multiple myeloma Blood(in press) DOI 10.1182/blood.2025031897, PubMed 41770814
Contact information: Group leader Fridtjof Lund-Johansen, Department of Immunology, Oslo University Hospital, Rikshospitalet, Tel: +47 23073016, E-mail: fridtjof.lund-johansen@rr-research.no
